Literature DB >> 2433038

Cisplatin-based treatment of adrenocortical carcinoma.

P J Hesketh, R P McCaffrey, H E Finkel, S S Larmon, G T Griffing, J C Melby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433038

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

Review 1.  Adrenal cortical carcinoma.

Authors:  A P Dackiw; J E Lee; R F Gagel; D B Evans
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

Review 2.  [Drug therapy of endocrine neoplasms. Part I: Thyroid neoplasms, adrenal neoplasms and parathyroid neoplasms].

Authors:  M Schott; W A Scherbaum; J Feldkamp
Journal:  Med Klin (Munich)       Date:  2000-01-15

3.  Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer.

Authors:  Tanweera S Khan; Anders Sundin; Claes Juhlin; Erik Wilander; Kjell Oberg; Barbro Eriksson
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

4.  Nonfunctioning adrenal cortical carcinoma with skeletal muscle metastasis: Case report and imaging at limited resource center.

Authors:  Ramakrishna Narra; Shaheen Syed; Nethula Sowjanya; Satyanarayana Veeragandham
Journal:  Radiol Case Rep       Date:  2022-03-03

Review 5.  Adrenal cortical carcinoma.

Authors:  R P Boushey; A P Dackiw
Journal:  Curr Treat Options Oncol       Date:  2001-08

6.  Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma.

Authors:  R Bonacci; A Gigliotti; E Baudin; N Wion-Barbot; P Emy; M Bonnay; A F Cailleux; I Nakib; M Schlumberger
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.